HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Previous close
$27.40
Day range
$27.86 - $29.14
Year range
$18.92 - $81.73
Market cap
3.19B USD
Avg Volume
4.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.47M | 62.79% |
Net income | -45.63M | -66.80% |
Net profit margin | — | — |
Earnings per share | -0.41 | -57.69% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 851.86M | -11.54% |
Total assets | 866.99M | -10.39% |
Total liabilities | 20.08M | -40.30% |
Total equity | 846.92M | — |
Shares outstanding | 112.31M | — |
Price to book | 3.63 | — |
Return on assets | -15.62% | — |
Return on capital | -16.04% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -45.63M | -66.80% |
Cash from operations | -52.33M | -753.13% |
Cash from investing | 63.24M | 113.76% |
Cash from financing | 349.00K | -99.94% |
Net change in cash | 11.26M | -91.96% |
Free cash flow | -40.61M | -1,953.60% |
About
CEO
Founded
2012
Website
Employees
46
